The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production
Abstract
Neuropathological hallmarks of Alzheimer's disease are neurofibrillary tangles composed of tau and neuritic plaques comprising amyloid-beta peptides (Abeta) derived from amyloid precursor protein (APP), but their exact relationship remains elusive. Phosphorylation of tau and APP on certain serine or threonine residues preceding proline affects tangle formation and Abeta production in vitro. Phosphorylated Ser/Thr-Pro motifs in peptides can exist in cis or trans conformations, the conversion of which is catalysed by the Pin1 prolyl isomerase. Pin1 has been proposed to regulate protein function by accelerating conformational changes, but such activity has never been visualized and the biological and pathological significance of Pin1 substrate conformations is unknown. Notably, Pin1 is downregulated and/or inhibited by oxidation in Alzheimer's disease neurons, Pin1 knockout causes tauopathy and neurodegeneration, and Pin1 promoter polymorphisms appear to associate with reduced Pin1 levels and increased risk for late-onset Alzheimer's disease. However, the role of Pin1 in APP processing and Abeta production is unknown. Here we show that Pin1 has profound effects on APP processing and Abeta production. We find that Pin1 binds to the phosphorylated Thr 668-Pro motif in APP and accelerates its isomerization by over 1,000-fold, regulating the APP intracellular domain between two conformations, as visualized by NMR. Whereas Pin1 overexpression reduces Abeta secretion from cell cultures, knockout of Pin1 increases its secretion. Pin1 knockout alone or in combination with overexpression of mutant APP in mice increases amyloidogenic APP processing and selectively elevates insoluble Abeta42 (a major toxic species) in brains in an age-dependent manner, with Abeta42 being prominently localized to multivesicular bodies of neurons, as shown in Alzheimer's disease before plaque pathology. Thus, Pin1-catalysed prolyl isomerization is a novel mechanism to regulate APP processing and Abeta production, and its deregulation may link both tangle and plaque pathologies. These findings provide new insight into the pathogenesis and treatment of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endosomal Aβ42 labeling by immuno-EM has since been confirmed by other groups [49, 95, 143].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [143]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Principles of Nuclear Magnetic Resonance in One and Two Dimensions
Ernst, R. R., Bodenhausen, G., Wokaun, A. J., & Redfield, A. G. (1989) · Physics Today · doi:10.1063/1.2811094 · Cited by 4,202
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Self-citationPrinciples of nuclear magnetic resonance in one and two dimensions
Redpath, T. W. (1988) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(88)90413-4 · Cited by 1,208
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 488
Del Prete, D., Rice, R. C., Rajadhyaksha, A. M., & D'Adamio, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733626 · Cited by 86
Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease
Harris, R. A., Tindale, L. C., & Cumming, R. C. (2014) · Biogerontology · doi:10.1007/s10522-014-9534-z · Cited by 85
Ma, S. L., Pastorino, L., Zhou, X. Z., & Lu, K. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c111.298596 · Cited by 86
Self-citationCheng, D., Yang, S., Zhao, X., & Wang, G. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s348055 · Cited by 84
Influence of the Trans/Cis Conformer Ratio on the Stereoselectivity of Peptidic Catalysts
Schnitzer, T., & Wennemers, H. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b06194 · Cited by 84
Rukhsana Sultana, A., & Butterfield, D. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129018 · Cited by 84
Tun-Kyi, A., Finn, G., Greenwood, A., Nowak, M. A., Lee, T. H., Asara, J. M., Tsokos, G. C., Fitzgerald, K., Israel, E., Li, X., et al. (2011) · Nature Immunology · doi:10.1038/ni.2069 · Cited by 83
Self-citationNeuronal protein trafficking associated with Alzheimer disease
Tang, B. L. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.1.7254 · Cited by 85
Chaperonopathies and chaperonotherapy
Macario, A. J. L., & de Macario, E. C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.030 · Cited by 83
Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics
Aluise, C. D., Sowell, R. A., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M. J., Markesbery, W. R., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.011 · Cited by 83
Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease
Hanger, D. P., Seereeram, A., & Noble, W. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.104 · Cited by 98
Protein Phosphorylation is a Key Mechanism in Alzheimer’s Disease
Oliveira, J. M., Costa, M. G. C., Cachide, M., Silva, O. A. B. D. C. E., & Henriques, A. G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170176 · Cited by 84
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 82
Eichner, T., & Radford, S. E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.013 · Cited by 81
Eroglu, B., Moskophidis, D., & Mivechi, N. F. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01493-09 · Cited by 84
Wolfe, M. S., & Guénette, S. Y. (2007) · Journal of Cell Science · doi:10.1242/jcs.03481 · Cited by 77
Inverse relationship between cancer and Alzheimer’s disease: a systemic review meta-analysis
Zhang, Q., Guo, S., Zhang, X., Tang, S. H., Shao, W., Han, X., Wang, L., & Du, Y. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2282-2 · Cited by 74
Namanja, A. T., Tao, P., Zintsmaster, J. S., Elson, A. C., Shakour, M. G., & Peng, J. W. (2007) · Structure · doi:10.1016/j.str.2007.01.014 · Cited by 74
Ma, S. L., Tang, N. L. S., Tam, C. W. C., Lui, V. W.-C., LAM, L. C. W., Chiu, H. F. K., Driver, J. A., Pastorino, L., & Lu, K. P. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.018 · Cited by 74
Self-citationLu, K. P., Kondo, A., Albayram, Ö., Herbert, M. K., Liu, H., & Zhou, X. Z. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2027 · Cited by 74
Self-citationMechanisms of amyloid fibril formation – focus on domain‐swapping
Žerovnik, E., Stoka, V., Mirtič, A., Gunčar, G., Grdadolnik, J., Staniforth, R. A., Turk, D., & Türk, V. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08149.x · Cited by 74
Peripheral Blood Mononuclear Cells as a Laboratory to Study Dementia in the Elderly
Arosio, B., D’Addario, C., Gussago, C., Casati, M., Tedone, E., Ferri, E., Nicolini, P., Rossi, P. D., Maccarrone, M., & Mari, D. (2014) · BioMed Research International · doi:10.1155/2014/169203 · Cited by 73
Brenkman, A. B., de Keizer, P. L. J., van den Broek, N. J. F., van der Groep, P., van Diest, P. J., van der Horst, A., de Vries-Smits, A. M. M., & Burgering, B. M. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1059 · Cited by 73
Membrane trafficking in neuronal maintenance and degeneration
Wang, D., Chan, C., Cherry, S., & Hiesinger, P. R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1201-4 · Cited by 74
Cis–trans isomerization of omega dihedrals in proteins
Craveur, P., Joseph, A. P., Poulain, P., de Brevern, A. G., & Rebehmed, J. (2013) · Amino Acids · doi:10.1007/s00726-013-1511-3 · Cited by 72
Esnault, S. J., Shen, Z.-J., Whitesel, E., & Malter, J. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6999 · Cited by 72
Rangasamy, V., Mishra, R., Sondarva, G. V., Das, S., Lee, T. H., Bakowska, J. C., Tzivion, G., Malter, J. S., Rana, B., Lu, K. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200804109 · Cited by 72
Self-citationValverde-Salazar, V., Ruiz-Gabarre, D., & García‐Escudero, V. (2023) · Antioxidants · doi:10.3390/antiox12071460 · Cited by 76
Nakatsu, Y., Sakoda, H., Kushiyama, A., Zhang, J., Ono, H., Fujishiro, M., Kikuchi, T., Fukushima, T., Yoneda, M., Ohno, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.206904 · Cited by 69
Molecular mechanisms of the phospho‐dependent prolyl cis/trans isomerase Pin1
Lippens, G. M., Landrieu, I., & Smet‐Nocca, C. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06057.x · Cited by 68
Prolyl Isomerase Pin1 Regulates Neuronal Differentiation via β-Catenin
Nakamura, K., Kosugi, I., Lee, D. Y., Hafner, A. V., Sinclair, D. A., Ryo, A., & Lu, K. P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05688-11 · Cited by 69
Self-citationTyr682 in the Intracellular Domain of APP Regulates Amyloidogenic APP Processing In Vivo
Barbagallo, A., Weldon, R., Tamayev, R., Zhou, D., Giliberto, L., Foreman, O., & D'adamio, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015503 · Cited by 66
Chinchalongporn, V., Shukla, M., & Govitrapong, P. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12470 · Cited by 66
Sano, Y., Nakaya, T., Pedrini, S., Takeda, S., Iijima‐Ando, K., Iijima, K., Mathews, P. M., Itohara, S., Gandy, S., & Suzuki, T. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000051 · Cited by 63
Sanokawa‐Akakura, R., Cao, W., Allan, K., Patel, K., Ganesh, A., Heiman, G. A., Burke, R., Kemp, F. W., Bogden, J. D., Camakaris, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008626 · Cited by 62
Proline-directed phosphorylation of the dopamine transporter N-terminal domain
Gorentla, B. K., Moritz, A. E., Foster, J., & Vaughan, R. (2009) · Biochemistry · doi:10.1021/bi801696n · Cited by 62
Robinson, R. A. S., Lange, M. L. B., Rukhsana Sultana, A., Galván, V., Fombonne, J., Gorostiza, O. F., Zhang, J., Warrier, G., Cai, J., Pierce, W. M. J., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.005 · Cited by 61
Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease
Chen, D., Zhou, X. Z., & Lee, T. H. (2018) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892814666181218170257 · Cited by 61
Self-citationCheng, H., Gang, X., Liu, Y., Wang, G., Zhao, X., & Wang, G. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2019 · Cited by 63
Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT
Stanya, K. J., Liu, Y., Means, A. R., & Kao, H. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806172 · Cited by 59
Park, K.-H., Jeon, J., Park, Y., Lee, S., Kwon, H.-J., Joo, C., Park, S., Han, H., & Cho, M. (2013) · The Journal of Physical Chemistry Letters · doi:10.1021/jz400954r · Cited by 59
Peptidyl-Prolyl Cis/Trans Isomerase Pin1 and Alzheimer’s Disease
Wang, L., Zhou, Y., Chen, D., & Lee, T. H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00355 · Cited by 66
Superoxide Anion, Uncoupling Proteins and Alzheimer’s Disease
Wu, Z., Zhao, Y., & Zhao, B. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.09-104-2 · Cited by 60
Pin1 affects Tau phosphorylation in response to Aβ oligomers
Bulbarelli, A., Lonati, E., Cazzaniga, E., Gregori, M., & Masserini, M. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.06.001 · Cited by 59
Novel modulators of amyloid‐β precursor protein processing
Tang, B. L., & Liou, Y. C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04215.x · Cited by 57
Complete determination of the Pin1 catalytic domain thermodynamic cycle by NMR lineshape analysis
Greenwood, A. I., Rogals, M. J., De, S., Lu, K. P., Kovrigin, E. L., & Nicholson, L. K. (2011) · Journal of Biomolecular NMR · doi:10.1007/s10858-011-9538-9 · Cited by 56
Self-citationMazzitelli, S., Xu, P., Ferrer, I., Davis, R. J., & Tournier, C. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4491-11.2011 · Cited by 57
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55
The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth
Zhou, F., Gong, K., Song, B., Ma, T., van Laar, T., Gong, Y., & Zhang, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.011 · Cited by 55
Zhou, W., Yang, Q., Low, C. B., Chandrababu, K. B., Wang, Y., Ryo, A., Yao, S. Q., Yang, D., & Liou, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022814 · Cited by 52
Targeting carcinogenesis: A role for the prolyl isomerase Pin1?
Lu, K. P., Suizu, F., Zhou, X. Z., Finn, G., Lam, P. B., & Wulf, G. M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20216 · Cited by 52
Self-citationZheng, F., Li, Y., Zhang, F., Sun, Y., Zheng, C., Luo, Z., Wang, Y.-L., Aschner, M., Zheng, H., Lin, L., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126378 · Cited by 51
Self-citationKim, B. M., You, M., Chen, C.-H., Suh, J., Tanzi, R. E., & Lee, T. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw114 · Cited by 52
Esnault, S. J., Shen, Z.-J., & Malter, J. S. (2008) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v28.i1.30 · Cited by 50
Relative Resistance of Cdk5-phosphorylated CRMP2 to Dephosphorylation
Cole, A. R., Soutar, M. P. M., Rembutsu, M., van Aalten, L., Hastie, C. J., McLauchlan, H., Peggie, M. W., Balaštík, M., Lu, K. P., & Sutherland, C. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801645200 · Cited by 50
Self-citationCarmo, S. D., Fournier, D., Mounier, C., & Rassart, É. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90725.2008 · Cited by 50
Pathogenic mechanisms in Alzheimer's disease
Pastorino, L., & Lu, K. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.078 · Cited by 52
Self-citationThe Role of Mitochondrial Quality Control in Cognitive Dysfunction in Diabetes
Luo, J.-S., Ning, J., Chen, Z.-Y., Li, W., Zhou, R., Yan, R., Chen, M., & Ding, L.-L. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03631-y · Cited by 52
Cis–trans peptide variations in structurally similar proteins
Joseph, A. P., Srinivasan, N., & de Brevern, A. G. (2012) · Amino Acids · doi:10.1007/s00726-011-1211-9 · Cited by 49
Regulation of Cardiac Hypertrophic Signaling by Prolyl Isomerase Pin1
Toko, H., Konstandin, M. H., Doroudgar, S., Ormachea, L., Joyo, E., Joyo, A. Y., Din, S., Gude, N. A., Collins, B. L., Völkers, M., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301084 · Cited by 49
Self-citationRukhsana Sultana, A., & Butterfield, D. A. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9123-x · Cited by 49
Nakatsu, Y., Matsunaga, Y., Yamamotoya, T., Ueda, K., Inoue, Y., Mori, K., Sakoda, H., Fujishiro, M., Ono, H., Kushiyama, A., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091495 · Cited by 50
Investigating dynamic interdomain allostery in Pin1
Peng, J. W. (2015) · Biophysical Reviews · doi:10.1007/s12551-015-0171-9 · Cited by 48
Structure and function of the human parvulins Pin1 and Par14/17
Matena, A., Rehic, E., Hönig, D., Kamba, B. E., & Bayer, P. (2017) · Biological Chemistry · doi:10.1515/hsz-2017-0137 · Cited by 50
NMR reveals novel mechanisms of protein activity regulation
Kalodimos, C. G. (2011) · Protein Science · doi:10.1002/pro.614 · Cited by 48
Mechanism of Action of Cyclophilin A Explored by Metadynamics Simulations
Leone, V., Lattanzi, G., Molteni, C., & Carloni, P. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000309 · Cited by 47
FKBP immunophilins and Alzheimer’s disease: A chaperoned affair
Cao, W., & Konsolaki, M. (2011) · Journal of Biosciences · doi:10.1007/s12038-011-9080-7 · Cited by 46
Activity-dependent isomerization of Kv4.2 by Pin1 regulates cognitive flexibility
Hu, J., Malloy, C., Tabor, G. T., Gutzmann, J. J., Liu, Y., Abebe, D. T., Karlsson, R., Durell, S. R., Cameron, H. A., & Hoffman, D. A. (2020) · Nature Communications · doi:10.1038/s41467-020-15390-x · Cited by 47
Robinson, R. A. S., Gururaj Joshi, A., Huang, Q., Rukhsana Sultana, A., Baker, A. S., Cai, J., Pierce, W. M. J., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2011) · PROTEOMICS · doi:10.1002/pmic.201000523 · Cited by 45
Krishnan, N., Lam, T. T., Fritz, A. J., Rempinski, D., O’Loughlin, K. L., Minderman, H., Berezney, R., Marzluff, W. F., & Thapar, R. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00382-12 · Cited by 46
Wang, H.-Y., Fu, J. C.-M., Lee, Y., & Lu, P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00475-13 · Cited by 46
Self-citationPousinha, P., Mouska, X., Raymond, E., Gwizdek, C., Dhib, G., Poupon, G., Zaragosi, L., Giudici, C., Bethus, I., Pacary, E., et al. (2017) · eLife · doi:10.7554/elife.25659 · Cited by 39
Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease
Zhang, T., Kim, B. M., & Lee, T. H. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00395-5 · Cited by 49
Pin1At Encoding a Peptidyl-Prolyl cis/trans Isomerase Regulates Flowering Time in Arabidopsis
Wang, Y., Liu, C., Yang, D., Yu, H. Q., & Liou, Y. (2010) · Molecular Cell · doi:10.1016/j.molcel.2009.12.020 · Cited by 45
Prolyl Isomerase Pin1 Regulates Axon Guidance by Stabilizing CRMP2A Selectively in Distal Axons
Balaštík, M., Zhou, X. Z., Alberich-Jordà, M., Weissová, R., Žiak, J., Pazyra‐Murphy, M. F., Cosker, K., Machoňová, O., Kozmiková, I., Chen, C.-H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.026 · Cited by 45
Self-citationUnderstanding the link between cancer and neurodegeneration
Driver, J. A. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.11.007 · Cited by 46
A ternary complex consisting of AICD, FE65, and TIP60 down-regulates Stathmin1
Müller, T., Schrötter, A., Looße, C., Pfeiffer, K., Theiß, C., Kauth, M., Meyer, H. E., & Marcus, K. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.07.017 · Cited by 44
Exclusively Heteronuclear NMR Experiments to Obtain Structural and Dynamic Information on Proteins
Bermel, W., Bertini, I., Felli, I. C., Peruzzini, R., & Pierattelli, R. (2010) · ChemPhysChem · doi:10.1002/cphc.200900772 · Cited by 44
Liu, T., Ren, D., Zhu, X., Yin, Z., Jin, G., Zhao, Z., Robinson, D., Li, X., Wong, K., Cui, K., et al. (2013) · Scientific Reports · doi:10.1038/srep03467 · Cited by 43
Self-citationProtein Oxidation in Aging and Alzheimer’s Disease Brain
Rukhsana Sultana, A., & Butterfield, D. A. (2024) · Antioxidants · doi:10.3390/antiox13050574 · Cited by 43
The role of Pin1 in the development and treatment of cancer
Min, S., Zhou, X. Z., & Lu, K. P. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0821-x · Cited by 41
Self-citationPousinha, P., Mouska, X., Bianchi, D., Temido-Ferreira, M., Rajão-Saraiva, J., Gomes, R., Fernandez, S., Salgueiro-Pereira, A. R., Gandin, C., Raymond, E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.103 · Cited by 29
Bicelles Rich in both Sphingolipids and Cholesterol and Their Use in Studies of Membrane Proteins
Hutchison, J. M., Shih, K., Scheidt, H. A., Fantin, S. M., Parson, K. F., Pantelopulos, G. A., Harrington, H. R., Mittendorf, K. F., Qian, S., Stein, R. A., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c04669 · Cited by 43
Karanth, S. D., Katsumata, Y., Nelson, P. T., Fardo, D. W., McDowell, J. K., Schmitt, F. A., Kryscio, R. J., Browning, S. R., Braithwaite, D., Arnold, S. M., et al. (2022) · Brain · doi:10.1093/brain/awac035 · Cited by 38
Sultana, R., Robinson, R. A. S., Di Domenico, F., Abdul, H. M., Clair, D. K. S., Markesbery, W. R., Cai, J., Pierce, W. M., & Butterfield, D. A. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.06.015 · Cited by 41
Driver, J. A., Zhou, X. Z., & Lu, K. P. (2014) · PubMed · Cited by 39
Self-citationPtdIns5P and Pin1 in oxidative stress signaling
Keune, W., Jones, D. R., & Divecha, N. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.02.001 · Cited by 42
Peng, H., Vijayakumar, S., Schiene‐Fischer, C., Li, H., Purkerson, J. M., Malešević, M., Liebscher, J., Al‐Awqati, Q., & Schwartz, G. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808964200 · Cited by 39
Khanal, P., Kim, G., Lim, S., Yun, H., Lee, K. Y., Choi, H., & Choi, H. S. (2013) · The FASEB Journal · doi:10.1096/fj.13-236851 · Cited by 44
Napoletano, F., Ferrari Bravo, G., Voto, I. A. P., Santin, A., Celora, L., Campaner, E., Dezi, C., Bertossi, A., Valentino, E., Santorsola, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109694 · Cited by 36
Deleersnijder, A., Rompuy, A. V., Desender, L., Pottel, H., Buée, L., Debyser, Z., Baekelandt, V., & Gérard, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182303 · Cited by 37
Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice
Götz, J., Schönrock, N., Vissel, B., & Ittner, L. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1143 · Cited by 38
Determinants of eosinophil survival and apoptotic cell death
Shen, Z.-J., & Malter, J. S. (2015) · APOPTOSIS · doi:10.1007/s10495-014-1072-2 · Cited by 36
Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration
Sorrentino, G., Comel, A., Mantovani, F., & Sal, G. D. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.08.003 · Cited by 36
Regulation of AU-Rich Element RNA Binding Proteins by Phosphorylation and the Prolyl Isomerase Pin1
Shen, Z.-J., & Malter, J. S. (2015) · Biomolecules · doi:10.3390/biom5020412 · Cited by 38
Zhang, Y., Lv, Z., Liu, Y., Cao, H., Yang, J., & Wang, B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9980444 · Cited by 36
Negative Regulation of Peptidyl-Prolyl Isomerase Activity by Interdomain Contact in Human Pin1
Wang, X., Mahoney, B. J., Zhang, M., Zintsmaster, J. S., & Peng, J. W. (2015) · Structure · doi:10.1016/j.str.2015.08.019 · Cited by 35
D’Addario, C., Candia, S. B., Arosio, B., Bartolomeo, M. D., Abbate, C., Casè, A., Candeletti, S., Romualdi, P., Damanti, S., Maccarrone, M., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.052 · Cited by 35
Oncogenic Hijacking of the PIN1 Signaling Network
Zannini, A., Rustighi, A., Campaner, E., & Sal, G. D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00094 · Cited by 37
Prolyl cis-trans Isomerization as a Molecular Timer in Crk Signaling
Nicholson, L. K., & Lu, K. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.005 · Cited by 35
Self-citation
Metadata
- Authors
- Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., Xia, W., Nicholson, L. K., & Lu, K. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Kaohsiung Veterans General Hospital (TW)
- Emory University (US)
- Brigham and Women's Hospital (US)
- Cornell University (US)
- Corresponding author
- Lu, Kun Ping
- ORCID
- Venue
- Nature
- Published
- 2006-03-23
- Volume
- 440
- Issue
- 7083
- Pages
- 528-534
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1974036368
- Cited by
- 487
- References
- 32
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 30 · 2023: 16 · 2022: 15 · 2021: 11 · 2020: 21 · 2019: 23 · 2018: 23 · 2017: 18 · 2016: 28 · 2015: 27 · 2014: 26 · 2013: 31 · 2012: 34
- FWCI
- 23.70
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-03-15)
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Science Foundation
- National Science Council
- National Institutes of Health
- National Institute on Aging (R01AG029385)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- peptidyl-prolyl isomerase, amyloid precursor protein, amyloid-beta production, Alzheimer's disease, cis-trans isomerization, APP phosphorylation, APP intracellular domain, tauopathy, neurofibrillary tangles, neuritic plaques, therapeutic target
- MeSH terms
- NIMA-Interacting Peptidylprolyl Isomerase, Alzheimer Disease, Animals, Catalysis, Cell Line, Cricetulus, Cricetinae, Humans, Phosphorylation, Protein Binding, Protein Processing, Post-Translational, Threonine, Transfection, Amyloid beta-Peptides, CHO Cells, Amyloid beta-Protein Precursor, Protein Structure, Tertiary, Mice, Knockout, Peptidylprolyl Isomerase, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review